|
Volumn 341, Issue 6142, 2013, Pages 137-138
|
Moving beyond "isolated" gene patents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENTARY DNA;
GENE;
INNOVATION;
LEGAL SYSTEM;
RESEARCH WORK;
CANCER RISK;
COURT;
DIAGNOSTIC TEST;
DNA ISOLATION;
GENE ISOLATION;
GENE MUTATION;
GENE SEQUENCE;
HUMAN;
INTRON;
LAW;
MEDICAL DECISION MAKING;
PATENT;
PRIORITY JOURNAL;
SHORT SURVEY;
TUMOR SUPPRESSOR GENE;
ARTICLE;
EXON;
GENE;
GENETICS;
JURISPRUDENCE;
LEGAL ASPECT;
UNITED STATES;
DNA, COMPLEMENTARY;
EXONS;
GENES;
GENES, BRCA1;
GENES, BRCA2;
GENETICS;
HUMANS;
INTRONS;
PATENTS AS TOPIC;
SUPREME COURT DECISIONS;
UNITED STATES;
MLCS;
MLOWN;
|
EID: 84880260571
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1242217 Document Type: Short Survey |
Times cited : (14)
|
References (9)
|